BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hernández Lozano I, Langer O. Use of imaging to assess the activity of hepatic transporters. Expert Opin Drug Metab Toxicol 2020;16:149-64. [PMID: 31951754 DOI: 10.1080/17425255.2020.1718107] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Storelli F, Yin M, Kumar AR, Ladumor MK, Evers R, Chothe PP, Enogieru OJ, Liang X, Lai Y, Unadkat JD. The next frontier in ADME science: Predicting transporter-based drug disposition, tissue concentrations and drug-drug interactions in humans. Pharmacology & Therapeutics 2022;238:108271. [DOI: 10.1016/j.pharmthera.2022.108271] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Nies AT, Schaeffeler E, Schwab M. Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation. Pharmacology & Therapeutics 2022;238:108268. [DOI: 10.1016/j.pharmthera.2022.108268] [Reference Citation Analysis]
3 Maeda K, Sugiyama Y. IN VITRO–IN VIVO SCALE‐UP OF DRUG TRANSPORT ACTIVITIES. Drug Transporters 2022. [DOI: 10.1002/9781119739883.ch22] [Reference Citation Analysis]
4 Masuo Y, Futatsugi A, Kato Y. EXPERIMENTAL APPROACHES FOR STUDYING DRUG TRANSPORTERS. In: You G, Morris ME, editors. Drug Transporters. Wiley; 2022. pp. 413-31. [DOI: 10.1002/9781119739883.ch20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pastor CM, Brouwer KLR. New Pharmacokinetic Parameters of Imaging Substrates Quantified from Rat Liver Compartments. Drug Metab Dispos 2022;50:58-64. [PMID: 34670777 DOI: 10.1124/dmd.121.000546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hernández-Lozano I, Mairinger S, Traxl A, Sauberer M, Filip T, Stanek J, Kuntner C, Wanek T, Langer O. Assessing the Functional Redundancy between P-gp and BCRP in Controlling the Brain Distribution and Biliary Excretion of Dual Substrates with PET Imaging in Mice. Pharmaceutics 2021;13:1286. [PMID: 34452247 DOI: 10.3390/pharmaceutics13081286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Marie S, Hernández-Lozano I, Breuil L, Truillet C, Hu S, Sparreboom A, Tournier N, Langer O. Imaging-Based Characterization of a Slco2b1(-/-) Mouse Model Using [11C]Erlotinib and [99mTc]Mebrofenin as Probe Substrates. Pharmaceutics 2021;13:918. [PMID: 34205780 DOI: 10.3390/pharmaceutics13060918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hernández-Lozano I, Wanek T, Sauberer M, Filip T, Mairinger S, Stanek J, Traxl A, Karch R, Schuetz JD, Langer O. Influence of ABC transporters on the excretion of ciprofloxacin assessed with PET imaging in mice. Eur J Pharm Sci 2021;163:105854. [PMID: 33865975 DOI: 10.1016/j.ejps.2021.105854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Marie S, Hernández-Lozano I, Langer O, Tournier N. Repurposing 99mTc-Mebrofenin as a Probe for Molecular Imaging of Hepatocyte Transporters. J Nucl Med 2021;62:1043-7. [PMID: 33674399 DOI: 10.2967/jnumed.120.261321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Marie S, Hernández-Lozano I, Breuil L, Saba W, Novell A, Gennisson JL, Langer O, Truillet C, Tournier N. Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [99mTc]mebrofenin Imaging in Rats. Pharmaceutics 2020;12:E486. [PMID: 32471244 DOI: 10.3390/pharmaceutics12060486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]